Stellenbeschreibung
The Leibniz-Institut für Analytische Wissenschaften - ISAS - e. V. develops efficient analytical methods for health research. Thus, it contributes to the improvement of the prevention, early diagnosis, and therapy of diseases like cardiovascular diseases or cancer. Overall, the institute strives to advance precision medicine by combining knowledge from different fields such as biology, chemistry, computer science, medicine, pharmacology, and physics. ISAS is a member of the Leibniz Association and is publicly funded by the Federal Republic of Germany and its federal states. This project, funded by the DFG as part of CRC 1752, \"DYNAMO: Immediate Tumor Dynamics in Melanoma Therapy“ (https://www.uni-due.de/crc1752/) seeks to combine high-resolution multi-omics profiling, advanced computational modeling, and clinically aligned biomarker stratification, in order to generate actionable, patient-specific predictions and resistance-targeting interventions in melanoma therapy. You will be responsible for finding out the role of neutrophils for the early development of therapy resistance in human melanoma. The project is being carried out in collaboration with University Hospital Essen and the University of Duisburg-Essen.
You will be responsible for
Experimental setup and execution of neutrophil functional profiling in the context of melanoma immune regulation and immune checkpoint inhibitor (ICI) response
Functional assays of neutrophils including migration, phagocytosis, and ROS production
Optimization and standardization of neutrophil functional assays for primary human samples
Few-cell proteomics for deep molecular characterization of neutrophil subsets
Multicolor flow cytometry of PBMCs and immune cell populations
Live-cell imaging and advanced microscopy for dynamic immune cell behavior analysis
Planning and execution of stimulation and inhibition experiments to dissect signaling pathways regulating neutrophil function in the melanoma context
Data processing, analysis, interpretation, and visualization of experimental results in collaboration with computational partners
Completed diploma or master’s degree in molecular biology, cancer biology, immunology, cell biology, bioinformatics, translational medicine or related disciplines
Experience in molecular and cellular biology techniques, ideally with hands-on experience with functional immune cell assays (preferably with neutrophils or myeloid cells) is an advantage
Strong interest in melanoma biology, tumor immunology, immune checkpoint therapy, translational cancer research, and tumor-immune interactions
Experience with cell culture, flow cytometry, microscopy, proteomics workflows or high-dimensional immune profiling approaches is desirable
Experience with bioinformatics or biostatistics is beneficial but not required
Ability to work independently and in interdisciplinary teams, with strong organizational skills and analytical thinking
High level of self-motivation, scientific curiosity, reliability, creativity, and team-oriented personality with enthusiasm to work in a collaborative research environment
Fluent in spoken and written English
A clear research topic as well as multifold training and support for PhD students in framework of ISAS and the Leibniz association
Opportunities for scientific training and development in an international environment and an excellent working atmosphere in a very dynamic and professional team
Access to state-of-the-art technologies including few-cell proteomics, high-dimensional flow cytometry, and advanced microscopy platforms
Integration into an interdisciplinary, internationally visible, translation-oriented cancer immunology research network
The opportunity to present your data on international conferences and participate in workshops
A wide range of opportunities for further training and qualifications
Flexible working times, mobile working and attractive social benefits
Family-friendly infrastructure and ...